Nuwellis, Inc. (NASDAQ:NUWE) Sees Large Increase in Short Interest

Nuwellis, Inc. (NASDAQ:NUWE) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 558,100 shares, a growth of 67.8% from the January 15th total of 332,600 shares. Currently, 49.8% of the company’s stock are sold short. Based on an average trading volume of 1,000,000 shares, the short-interest ratio is presently 0.6 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Nuwellis stock. Geode Capital Management LLC bought a new stake in Nuwellis, Inc. (NASDAQ:NUWE) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned approximately 0.70% of Nuwellis at the end of the most recent quarter. 3.13% of the stock is owned by hedge funds and other institutional investors.

Nuwellis Trading Down 0.8 %

Shares of NUWE stock traded down $0.01 during trading hours on Friday, hitting $1.29. 149,008 shares of the company were exchanged, compared to its average volume of 1,079,352. The business has a 50 day moving average of $1.17 and a two-hundred day moving average of $1.48. Nuwellis has a 52 week low of $0.92 and a 52 week high of $27.61. The company has a market capitalization of $5.64 million, a PE ratio of -0.01 and a beta of 0.31.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.